Finerenone Treatment Slows Chronic Kidney Disease Progression After Heart Failure Hospitalization

A numerically slower decline in eGFR was reported in the finerenone cohort after hospitalization for heart failure when compared with placebo.

Related Keywords

,Jeroldb Katz ,Tariq Shafi ,Division Of Kidney Diseases ,National Kidney Foundation ,Houston Methodist Hospital ,Kidney Diseases ,Houston Methodist ,